Marina Lalakin
@Sectoral Asset Management Inc
Latest period2024 - Q3ReportedManaged Assets$169.299MTotal holdings90
Assets growth rate-31.19%Assets growth rate (2-Q avg)-17.23%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Sectoral Asset Management Inc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 90 positions.
Assets under management
The assets under management (AUM) of Sectoral Asset Management Inc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 169.299M in assets, with a quarterly growth rate of -31.19% and a 2-quarter average growth rate of -17.23%. The portfolio is managed by Marina Lalakin, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BMYBristol Myers Squibb
| 1.53% | $2.587M 50,000 shares@ $51.74 avg price | Increased 66.67% |
ZLABZai Lab Ltd
| 1.04% | $1.759M 72,870 shares@ $24.15 avg price | Increased 3543.5% |
EWEdwards Lifescience
| 1.01% | $1.706M 25,850 shares@ $66.0 avg price | Increased 65.18% |
NBIXNeurocrine Bioscienc
| 0.86% | $1.442M 12,515 shares@ $115.22 avg price | Increased 218.05% |
BPMCBlueprint Medicines
| 0.82% | $1.38M 14,920 shares@ $92.5 avg price | Increased 287.54% |
MLTXMoonlake Immunothera
| 0.82% | $1.374M 27,258 shares@ $50.42 avg price | Increased 27.21% |
LEGNLegend Biotech Corp
| 0.79% | $1.325M 27,200 shares@ $48.73 avg price | Increased 1260% |
ARVNArvinas Inc
| 0.67% | $1.129M 45,830 shares@ $24.64 avg price | Increased 31.59% |
GPCRStructure Therapeu
| 0.64% | $1.071M 24,395 shares@ $43.9 avg price | Increased 82.53% |
RCKTRocket Pharmaceutica
| 0.48% | $801,284 43,383 shares@ $18.47 avg price | Increased 246.24% |